Conatus Pharmaceuticals Announces Upcoming Oral Presentation at EASL Annual Meeting
April 09, 2018 07:30 ET
|
Conatus Pharmaceuticals Inc.
SAN DIEGO, April 09, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), a biotechnology company focused on the development of novel medicines to treat liver disease, today...
Conatus Pharmaceuticals Announces Top-line Results from Phase 2b POLT-HCV-SVR Clinical Trial
April 04, 2018 16:05 ET
|
Conatus Pharmaceuticals Inc.
Biopsy-based Proof of Concept in Liver Fibrosis and Cirrhosis Supports Further Evaluation Conference Call and Webcast Presentation at 4:30 p.m. ET Today SAN DIEGO, April 04, 2018 (GLOBE NEWSWIRE)...
Conatus Pharmaceuticals Reports 2017 Financial Results and Program Updates
March 07, 2018 16:05 ET
|
Conatus Pharmaceuticals Inc.
SAN DIEGO, March 07, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver...
Conatus Pharmaceuticals to Highlight Anticipated Clinical Data Readouts at Upcoming Investor Conferences
March 05, 2018 07:30 ET
|
Conatus Pharmaceuticals Inc.
SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) -- At three upcoming investor conferences in March, Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) President, Chief Executive Officer and co-founder, Steven J....
Conatus Pharmaceuticals to Report Fourth Quarter and Full Year 2017 Financial Results
February 28, 2018 07:30 ET
|
Conatus Pharmaceuticals Inc.
SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced that it will report financial results for the fourth quarter and full year ended December 31,...
Conatus Pharmaceuticals to Host Expert Call on Unmet Need in HCV-SVR Patients
February 12, 2018 07:30 ET
|
Conatus Pharmaceuticals Inc.
SAN DIEGO, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) will host a conference call and webcast presentation at 12:00 p.m. ET on Tuesday, February 20, with liver...
Conatus Pharmaceuticals to Highlight Anticipated Clinical Data Readouts and Strategic Initiatives at Upcoming Investor Events
February 05, 2018 07:30 ET
|
Conatus Pharmaceuticals Inc.
SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- In a presentation and in scheduled meetings with members of the investment community in New York next week, Conatus Pharmaceuticals Inc. (NASDAQ:CNAT)...
Conatus to Present at Stifel Healthcare Conference
November 07, 2017 07:30 ET
|
Conatus Pharmaceuticals Inc.
SAN DIEGO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced its scheduled presentation to provide an overview of the company’s programs and outlook at the...
Conatus Pharmaceuticals Reports Third Quarter 2017 Financial Results and Program Updates
November 01, 2017 16:05 ET
|
Conatus Pharmaceuticals Inc.
SAN DIEGO, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver...
Conatus Pharmaceuticals to Report Third Quarter 2017 Financial Results
October 25, 2017 07:30 ET
|
Conatus Pharmaceuticals Inc.
SAN DIEGO, Calif., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced that it will report financial results for the third quarter ended September 30, 2017,...